{"title":"Nebulized MSC exosomes promote the transdifferentiation of transitional state cells against acute lung injury through STAT3/Krt8/AQP5 axis","authors":"Yue Tang, Jingyuan Qian, Meng Ding, Rui Ding, Pengwei Yang, Yushun Dou","doi":"10.1016/j.ejpb.2025.114792","DOIUrl":null,"url":null,"abstract":"<div><div>The transdifferentiation of alveolar epithelial type II cells (AECIIs) to alveolar epithelial type I cells (AECIs) plays an important role in the epithelial repair in acute lung injury (ALI). Although transitional state cells have been reported to regenerate the alveolar epithelium surface and promote a repair process, the treatment of ALI based on transitional state cells has not been suggested.</div><div>Here, we demonstrate that nebulized mesenchymal stem cell exosomes (MSC exosomes) can be used for ALI and MSC exosomes have the ability to promote the differentiation of transitional state cells into AECIs by regulating the STAT3/Krt8/AQP5 axis. In the in vivo study, immunohistochemistry and immunofluorescence staining results showed that MSC exosomes could reduce the expression of transitional state cells and promote transdifferentiation of AECIIs. In the in vitro study, western blotting (WB) results showed that MSC exosomes downregulated signal transducer and activator of transcription 3 (STAT3) phosphorylation and the expression of transitional state cell specific keratin 8 (Krt8), and upregulated the expression of AECIs specific aquaporin 5 (AQP5). The results indicate that MSC exosomes inhibit STAT3 phosphorylation through STAT3/Krt8/AQP5 axis, promote the transdifferentiation of transitional state cells to AECIs and accelerate the regeneration of alveolar epithelium after LPS-induced lung injury. Regulating transitional state cells to alleviate ALI is suggested for the first time.</div></div>","PeriodicalId":12024,"journal":{"name":"European Journal of Pharmaceutics and Biopharmaceutics","volume":"214 ","pages":"Article 114792"},"PeriodicalIF":4.4000,"publicationDate":"2025-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Pharmaceutics and Biopharmaceutics","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0939641125001699","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
The transdifferentiation of alveolar epithelial type II cells (AECIIs) to alveolar epithelial type I cells (AECIs) plays an important role in the epithelial repair in acute lung injury (ALI). Although transitional state cells have been reported to regenerate the alveolar epithelium surface and promote a repair process, the treatment of ALI based on transitional state cells has not been suggested.
Here, we demonstrate that nebulized mesenchymal stem cell exosomes (MSC exosomes) can be used for ALI and MSC exosomes have the ability to promote the differentiation of transitional state cells into AECIs by regulating the STAT3/Krt8/AQP5 axis. In the in vivo study, immunohistochemistry and immunofluorescence staining results showed that MSC exosomes could reduce the expression of transitional state cells and promote transdifferentiation of AECIIs. In the in vitro study, western blotting (WB) results showed that MSC exosomes downregulated signal transducer and activator of transcription 3 (STAT3) phosphorylation and the expression of transitional state cell specific keratin 8 (Krt8), and upregulated the expression of AECIs specific aquaporin 5 (AQP5). The results indicate that MSC exosomes inhibit STAT3 phosphorylation through STAT3/Krt8/AQP5 axis, promote the transdifferentiation of transitional state cells to AECIs and accelerate the regeneration of alveolar epithelium after LPS-induced lung injury. Regulating transitional state cells to alleviate ALI is suggested for the first time.
期刊介绍:
The European Journal of Pharmaceutics and Biopharmaceutics provides a medium for the publication of novel, innovative and hypothesis-driven research from the areas of Pharmaceutics and Biopharmaceutics.
Topics covered include for example:
Design and development of drug delivery systems for pharmaceuticals and biopharmaceuticals (small molecules, proteins, nucleic acids)
Aspects of manufacturing process design
Biomedical aspects of drug product design
Strategies and formulations for controlled drug transport across biological barriers
Physicochemical aspects of drug product development
Novel excipients for drug product design
Drug delivery and controlled release systems for systemic and local applications
Nanomaterials for therapeutic and diagnostic purposes
Advanced therapy medicinal products
Medical devices supporting a distinct pharmacological effect.